Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.75B.
ENTERPRISE VALUE (EV)
$1.75B
Syndax Pharmaceuticals, Inc.
Market Cap
$1.54B
Enterprise Value (EV)
$1.75B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.54B | $1.75B |
| Innoviva, Inc. (INVA)vs › | $1.54B | $1.24B |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | $1.47B |
| Nutex Health, Inc. (NUTX)vs › | $1.50B | $1.65B |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | $1.50B |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | $1.60B |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | $1.44B |
| Phibro Animal Health Corporation (PAHC)vs › | $1.48B | $2.21B |
| uniQure N.V. (QURE)vs › | $1.60B | $1.25B |
| GH Research PLC (GHRS)vs › | $1.48B | $1.13B |
Market Cap
$1.54B
Total Debt
$344.96M
Cash
$134.93M
Enterprise Value
$1.75B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
